Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLCO4A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101927826 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TET1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC38A10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFIL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR1908 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XYLT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERO1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCARNA15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR3652 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FKBP11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC1A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBA5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB11A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PICALM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLTF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on